Fox Run Management L.L.C. Sells 9,220 Shares of Maximus, Inc. (NYSE:MMS)

Fox Run Management L.L.C. decreased its holdings in Maximus, Inc. (NYSE:MMS) by 51.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 8,558 shares of the health services provider’s stock after selling 9,220 shares during the period. Fox Run Management L.L.C.’s holdings in Maximus were worth $639,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. grew its position in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after buying an additional 158 shares during the last quarter. Eastern Bank bought a new stake in Maximus in the fourth quarter valued at approximately $29,000. V Square Quantitative Management LLC increased its position in Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 180 shares during the period. R Squared Ltd bought a new position in Maximus during the 4th quarter worth approximately $54,000. Finally, IFP Advisors Inc boosted its stake in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Price Performance

Maximus stock opened at $66.48 on Tuesday. The stock’s 50 day moving average price is $70.86 and its two-hundred day moving average price is $78.31. The stock has a market capitalization of $3.76 billion, a price-to-earnings ratio of 14.30 and a beta of 0.71. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, equities analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date of this dividend was Friday, February 14th. Maximus’s payout ratio is 25.81%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

Insider Buying and Selling

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.